🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
BMY
$BMY
🔒 US EquitiesBristol-Myers Squibb Company
AVG HISTORICAL GAP
-0.59%
MAX GAP RECORD
-4.68%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $BMY
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$BMY
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (BEFORE OPEN (08:00)) |
+0.71%
|
| Jul 30, 2026 Earnings Release 2026-07-30 (BEFORE OPEN) |
-0.28%
|
| Apr 30, 2026 Earnings Release 2026-04-30 (AFTER CLOSE) |
+0.47%
|
| Feb 05, 2026 Earnings Release 2026-02-05 (BEFORE OPEN) |
+2.24%
|
| Oct 30, 2025 Earnings Release 2025-10-30 (BEFORE OPEN) |
+1.57%
|
| Jul 29, 2025 Earnings Release 2025-07-29 (BEFORE OPEN) |
-0.13%
|
| Apr 28, 2025 Earnings Release 2025-04-28 (BEFORE OPEN) |
+0.35%
|
| Jan 29, 2025 Earnings Release 2025-01-29 (BEFORE OPEN) |
-0.86%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.4%
Bullish Gaps (3)
Bearish Gaps (6)
Neutral / Flat (7)
📖 Intelligence Summary
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and psoriatic arthritis;…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗